HealthEquity raises fiscal 2027 revenue guidance to $1.411 bln-$1.421 bln
Company expects fiscal 2027 net income of $242 mln-$248 mln, or $2.88-$2.96 per share
HealthEquity sees fiscal 2027 Adjusted EBITDA of $628 mln-$636 mln
Overview
U.S. HSA custodian's Q2 revenue rose 8%, slightly beating analyst expectations
Adjusted EPS for Q2 beat analyst expectations
Company repurchased $108.1 mln in stock during the quarter
Result Drivers
HSA account growth - Total HSA accounts rose 8% year over year to 10.7 mln, with new HSAs from sales up 24%
HSA asset increase - Total HSA assets grew 14% to $37.9 bln, driven by higher HSA investments and cash balances
Technology-enabled efficiency - Co said improved technology and operational efficiency contributed to results, per CEO Scott Cutler
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
HQY•
